Overview

Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To determine whether supplementation of omega-3 long-chain polyunsaturated fatty acid conjugated to phosphatidylserine rather than triglycerides (fish oil) could affect Attention-deficit/hyperactivity disorder symptoms in children.
Phase:
Phase 2
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center